MM+M Podcast 7.19.22: J&J’s Tylenol embraces ‘beyond the pill’

Adam Ricciardone, global head of self care R&D at Johnson & Johnson Consumer Health, discusses how Tylenol embraced a “beyond-the-pill” strategy.

MM+M Staff

July 19, 2022

12:00 pm

Adam Ricciardone, global head of self care R&D at Johnson & Johnson Consumer Health, discusses how 70-year-old Tylenol embraced a “beyond-the-pill” strategy, as well as how it fits in the context of the pharma industry’s overall shift toward promoting self-care.

From Our Partners

What’s on the mind of population-health decision makers

Partner Content

What’s on the mind of population-health decision makers 

Spherico, a division of GSW recently conducted a survey among payers to gain insight into their behaviors, identify trends and better understand what is impacting them day to day.

Triple Threat Communications: Working with the Unagency

Partner Content

Triple Threat Communications: Working with the Unagency

How a different kind of ad agency is putting clients first.

Point of connection: How social is changing the game in healthcare marketing

Partner Content

Point of connection: How social is changing the game in healthcare marketing

Patients are becoming more educated about their health conditions and potential treatment options and are now more engaged than ever on social media as they search, ask, engage, and advocate on these platforms.

HLTH 2022 focuses on consumer expectations, digital health capabilities

Partner Content

HLTH 2022 focuses on consumer expectations, digital health capabilities

The conference also highlighted the growing importance of behavioral health and underscored trends accelerated by the COVID-19 pandemic.